Roles of ceramides in development of insulin resistance (Homo sapiens)
From WikiPathways
Description
Ceramides are produced mostly by the sphingolipid pathway. Besides the sphingolipid pathway, ceramides are also produced by the hydrolysis of sphingomyelin with the catalysis of nSMase2.
In the cell, ceramides play a role in insulin resistance. Ceramides inhibit the binding of PDX-1 and MAFA transcription factors to insulin promoter. Ceramides cause ER stress, which activates extracellular signal-regulated kinase MAPK8 and EIF2AK2. This leads to the upregulation of serine phosphorylation while downregulating tyrosine phosphorylation of IRS-1. That, in turn, leads to the inhibition of recruitment and activation of PI3K. This leads to a downregulation in AKT1, an enzyme that stimulates the translocation of GLUT4. Ceramides also impair mitochondria functions and inhibit fatty acid oxidation, eventually leading to ROS and inflammation. Ceramides activate protein PP2A, which promotes the dephosphorylation of AKT1. PKCζ is also activated by ceramides to inhibit the activity of AKT1.
Moreover, palmitoyl-CoA downregulates the phosphorylation of AMPK, which leads to the increase of ER stress in the cell and decreases in fatty acid oxidation.
On the other hand, oleic acid inhibits the downregulation of AMPK caused by palmitoyl-CoA. Oleic acid also increases the expression of CPT1B, stimulating the fatty acid oxidation to reduce the inflammation in the cell.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Salvadó L, Palomer X, Barroso E, Vázquez-Carrera M; ''Targeting endoplasmic reticulum stress in insulin resistance.''; Trends Endocrinol Metab, 2015 PubMed Europe PMC Scholia
- Sindhu S, Leung YH, Arefanian H, Madiraju SRM, Al-Mulla F, Ahmad R, Prentki M; ''Neutral sphingomyelinase-2 and cardiometabolic diseases.''; Obes Rev, 2021 PubMed Europe PMC Scholia
- Bar-Tana J, Rose G, Brandes R, Shapiro B; ''Palmitoyl-coenzyme A synthetase. Mechanism of reaction.''; Biochem J, 1973 PubMed Europe PMC Scholia
- Bellini L, Campana M, Mahfouz R, Carlier A, Véret J, Magnan C, Hajduch E, Le Stunff H; ''Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.''; Expert Opin Ther Targets, 2015 PubMed Europe PMC Scholia
- Pinter K, Grignani RT, Watkins H, Redwood C; ''Localisation of AMPK γ subunits in cardiac and skeletal muscles.''; J Muscle Res Cell Motil, 2013 PubMed Europe PMC Scholia
- Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA; ''Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.''; Mediators Inflamm, 2010 PubMed Europe PMC Scholia
- Palomer X, Pizarro-Delgado J, Barroso E, Vázquez-Carrera M; ''Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus.''; Trends Endocrinol Metab, 2018 PubMed Europe PMC Scholia
- Lim JH, Gerhart-Hines Z, Dominy JE, Lee Y, Kim S, Tabata M, Xiang YK, Puigserver P; ''Oleic acid stimulates complete oxidation of fatty acids through protein kinase A-dependent activation of SIRT1-PGC1α complex.''; J Biol Chem, 2013 PubMed Europe PMC Scholia
- Al-Rashed F, Ahmad Z, Thomas R, Melhem M, Snider AJ, Obeid LM, Al-Mulla F, Hannun YA, Ahmad R; ''Neutral sphingomyelinase 2 regulates inflammatory responses in monocytes/macrophages induced by TNF-α.''; Sci Rep, 2020 PubMed Europe PMC Scholia
- Miljkovic I, Yerges LM, Li H, Gordon CL, Goodpaster BH, Kuller LH, Nestlerode CS, Bunker CH, Patrick AL, Wheeler VW, Zmuda JM; ''Association of the CPT1B gene with skeletal muscle fat infiltration in Afro-Caribbean men.''; Obesity (Silver Spring), 2009 PubMed Europe PMC Scholia
- Kirwan JP; ''Plasma ceramides target skeletal muscle in type 2 diabetes.''; Diabetes, 2013 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
ACSL1 | Protein | P33121 (Uniprot-TrEMBL) | The activation is catalyzed by palmitoyl-coenzyme A synthetase |
AKT1 | GeneProduct | ENSG00000142208 (Ensembl) | |
AMPK | Protein | Q9UGI9 (Uniprot-TrEMBL) | |
CD36/FAT | Protein | P16671 (Uniprot-TrEMBL) | |
CPT1B | Protein | Q92523 (Uniprot-TrEMBL) | |
EIF2AK2 | GeneProduct | ENSG00000055332 (Ensembl) | Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2 |
ERN1 | Protein | O75460 (Uniprot-TrEMBL) | |
Fatty Acid Oxidation | Pathway | WP143 (WikiPathways) | |
GLUT4 translocation | Pathway | WP2777 (WikiPathways) | |
GLUT4 | Protein | P14672 (Uniprot-TrEMBL) | |
INSR | Protein | P06213 (Uniprot-TrEMBL) | |
IRS-1 | Protein | P35568 (Uniprot-TrEMBL) | |
IRS-2 | Protein | Q9Y4H2 (Uniprot-TrEMBL) | |
Insulin | Protein | P01308 (Uniprot-TrEMBL) | |
MAFA | Protein | Q8NHW3 (Uniprot-TrEMBL) | |
MAPK8 | GeneProduct | ENSG00000107643 (Ensembl) | |
OA | Metabolite | HMDB0000207 (HMDB) | Oleic acid |
Oleic acid | Metabolite | HMDB0000207 (HMDB) | |
Oxidative stress response | Pathway | WP408 (WikiPathways) | |
PDX1 | GeneProduct | P52945 (Uniprot-TrEMBL) | |
PI3K | Protein | P27986 (Uniprot-TrEMBL) | PI3K subunit alpha |
PKCzeta | Protein | Q05513 (Uniprot-TrEMBL) | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
PP2A | Protein | P67775 (Uniprot-TrEMBL) | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
Palmitate | Metabolite | CHEBI:15756 (ChEBI) | |
Palmitoyl-CoA | Metabolite | CHEBI:15525 (ChEBI) | |
ROS | Metabolite | 26523 (ChEBI) | |
RPS6KB1 | Protein | P23443 (Uniprot-TrEMBL) | |
Sphingolipid pathway | Pathway | WP1422 (WikiPathways) | |
Sphingomyelin | Metabolite | CHEBI:89490 (ChEBI) | |
TNF-alpha | Protein | P01375 (Uniprot-TrEMBL) | |
TNFR | Protein | P19438 (Uniprot-TrEMBL) | |
TRAF1 | Protein | Q13077 (Uniprot-TrEMBL) | |
ceramide | Metabolite | CHEBI:52639 (ChEBI) | |
glucose | Metabolite | CHEBI:17234 (ChEBI) | |
nSMase2 | Protein | Q9NY59 (Uniprot-TrEMBL) | Sphingomyelin phosphodiesterase 2 |
Annotated Interactions
No annotated interactions